FDA Warning Letter — ImprimisRx CA, Inc., dba ImprimisRx
The FDA took a Warning Letter action against ImprimisRx CA, Inc., dba ImprimisRx on March 20, 2017 (Irvine, CA). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- ImprimisRx CA, Inc., dba ImprimisRx
- Date
- March 20, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Irvine, CA (United States)